Achilles Tendinopathy Clinical Trial
Official title:
A Two Part, Randomized, Participant and Investigator-blinded, 2-arm, Parallel-design, Placebo-controlled Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles on Tendon Regeneration in Patients With Achilles Tendinopathy
The purpose of this study is to measure local and systemic safety and tolerability as well as improvement of Achilles tendon mechanical properties after a single peritendon injection of NGI226 MP in comparison to placebo MP in patients with mid-portion Achilles tendinopathy.
Status | Recruiting |
Enrollment | 46 |
Est. completion date | July 1, 2025 |
Est. primary completion date | July 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 70 Years |
Eligibility | Inclusion Criteria: - Written informed consent must be obtained prior to all study specific screening procedures, as close to the start of the screening period as possible. - Presence of clinically (local Achilles tendon pain on tendon-loading activities, pain on palpation at the level 2-6 cm proximal to the calcaneal insertion) and ultrasound (local tendon thickening with hypoechogenicities and irregular fibre orientation) or MRI diagnosed mid-portion Achilles tendinopathy with symptoms present =8 weeks but <12 months at screening. - The Achilles tendinopathy must have been refractory to at least 6 weeks of conservative treatment (physiotherapy, NSAIDS, RICE), but participants do not need to be in physiotherapy at the time of study entry. Exclusion Criteria: - Medical condition that would affect safety of peritendon injection (e.g., peripheral vascular disease, use of anticoagulant medication) - History of recurrent, acute, symptomatic infections, including outbreaks of oral or genital herpes (> 2 symptomatic infections or >2 courses of anti-infective treatments required in the last 6 months; active systemic infection during last 2 weeks; known active infections (e.g. chronic or active Hepatis B or C, HIV) - simple cold excluded - History or evidence of clinically significant cardiac or cardiovascular disease - History of deep vein thrombosis, pulmonary embolism or evidence of primary or secondary hypercoagulable states - History of surgical intervention for the treatment of tendinopathy, history of ankle surgery, ankle arthritis, traumatic, inflammation or deformity of ankle - History of full-thickness tear or complete rupture of the Achilles tendon |
Country | Name | City | State |
---|---|---|---|
France | Novartis Investigative Site | Caluire et Cuire | |
France | Novartis Investigative Site | Nantes Cedex 1 | |
Germany | Novartis Investigative Site | Berlin | |
Germany | Novartis Investigative Site | Hamburg | |
United Kingdom | Novartis Investigative Site | Glasgow | |
United States | Advanced Research LLC | Deerfield Beach | Florida |
United States | Houston Methodist Hospital | Houston | Texas |
United States | Tucson Orthopedic Institute | Tucson | Arizona |
Lead Sponsor | Collaborator |
---|---|
Novartis Pharmaceuticals |
United States, France, Germany, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants with AEs and SAEs | AEs and SAEs including ECG parameters, Lab Chemistry and Hematology parameters, urinalysis, local tolerability | Up to Day 169 (End of Study) | |
Secondary | Changes in tendon stiffness from baseline at week 12 assessed by ultrasound (US)-based shear wave elastography (SWE) | To assess the effects of a single peritendon injection of NGI226 MP versus placebo on restoration of biomechanical integrity of Achilles tendon | Baseline, Week 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04221711 -
Safety and Efficacy of Repetitive Peripheral Magnetic Stimulation in Patients With Achilles Tendinopathy
|
N/A | |
Completed |
NCT06057779 -
The Effect of Loading Speed and Intensity During Exercise on the Immediate Structural Changes in the Achilles Tendon
|
N/A | |
Active, not recruiting |
NCT00835939 -
Treatment for Achilles Tendinopathy
|
Phase 2/Phase 3 | |
Completed |
NCT04059146 -
Tendinopathy Education on the Achilles
|
N/A | |
Active, not recruiting |
NCT06030908 -
Outcome After Surgical Reconstruction of the Achilles Tendon Insertion.
|
||
Recruiting |
NCT04423900 -
Smart Phone-Based Application for Evaluation and Rehabilitation of HindFoot Pain
|
N/A | |
Completed |
NCT04632979 -
Backward Running on a Negative Slope as a Treatment for Achilles Tendinopathy in Runners
|
N/A | |
Terminated |
NCT03264326 -
Efficacy of BFR Training Combined With Eccentric Exercise as Assessed by SWE in Subjects With Chronic AT
|
N/A | |
Completed |
NCT04941469 -
Effectiveness of Specifically Optimized Off-the-counter Foot Orthosis for the Subtle Cavus Foot
|
N/A | |
Completed |
NCT04376294 -
Using of Extracorporeal Shockwave Therapy in Treatment Of Achilles Tendinopathy
|
N/A | |
Recruiting |
NCT06056440 -
Efficacy of a Physical Rehabilitation Program Using Virtual Reality in Patients With Chronic Tendinopathy (Virtendon-Rehab)
|
N/A | |
Recruiting |
NCT06172218 -
AM for Refractory Achilles Tendinopathy
|
N/A | |
Recruiting |
NCT05105269 -
Managing Achilles Pain II
|
||
Completed |
NCT06297317 -
Longitudinal Changes in Achilles Tendon and Medial Gastrocnemius Muscle Architecture During a 156-km Ultradistance Trail Running Event
|
||
Recruiting |
NCT06100822 -
Managing Chronic Tendon Pain by Metformin
|
Phase 1 | |
Completed |
NCT03067545 -
Do Simple Running Technique Changes Reduce Pain and Change Injury Causing Mechanics
|
N/A | |
Recruiting |
NCT01583504 -
High Volume Saline Injections for Achilles Tendinopathy
|
N/A | |
Completed |
NCT04816188 -
Heel Pain in Adolescents: A Pilot Study on the Effectiveness of Exercise Therapy and Activity Modification
|
N/A | |
Completed |
NCT05125198 -
Translation, Cultural Adaptation and Validation of Urdu Version of VISA-A Questionnaire
|
||
Recruiting |
NCT05464498 -
Evaluation of Collagen-based Medical Device Treatment Combined With Physiotherapy in Subjects With Achilles Tendinopathy.
|
N/A |